Literature DB >> 8948462

Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58.

M P Chadwick1, F E May, B R Westley.   

Abstract

The preparation and purification of recombinant mature pNR-2/pS2, a single-domain member of the 'trefoil' family of cysteine-rich secreted proteins, is described. Analysis of recombinant pNR-2/pS2 by ion-exchange chromatography showed that it was heterogeneous. The heterogeneity was reduced by treatment with thiol-group-containing reagents, suggesting that it is caused by the odd number of cysteine residues in mature pNR-2/pS2, and this view was reinforced by mutation of the extra-trefoil domain cysteine residue, Cys58, to a serine residue. Electrophoresis of recombinant pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58 proteins under non-denaturing conditions confirmed that the Ser58 mutant is much more homogeneous, and showed that most of pNR-2/pS2 Ser58 co-migrates as a single band with pNR-2/pS2 secreted from breast-cancer cells in culture. Treatment of recombinant pNR-2/pS2 proteins with various thiol-group-reactive reagents indicated that cysteine is the most effective at producing recombinant pNR-2/pS2 that co-migrates with pNR-2/pS2 secreted by breast-cancer cells. Dithiothreitol appeared to denature the proteins, and GSH was relatively ineffective. pNR-2/pS2 Cys58 treated with cysteine and untreated pNR-2/pS2 Ser58 had the same apparent molecular mass, measured by gel filtration, as pNR-2/pS2 secreted from breast-cancer cells. This is the first report of the production of a recombinant mature single-domain trefoil peptide and should greatly facilitate elucidation of the structure and function of pNR-2/pS2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8948462      PMCID: PMC1136822          DOI: 10.1042/bj3081001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Expression and purification of recombinant insulin-like growth factors from Escherichia coli.

Authors:  B Nilsson; G Forsberg; M Hartmanis
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

Authors:  N A Wright; R Poulsom; G Stamp; S Van Noorden; C Sarraf; G Elia; D Ahnen; R Jeffery; J Longcroft; C Pike
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

3.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.

Authors:  F Hauser; R Poulsom; R Chinery; L A Rogers; A M Hanby; N A Wright; W Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.

Authors:  A D Thor; F C Koerner; S M Edgerton; W C Wood; M A Stracher; L H Schwartz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry.

Authors:  N H Piggott; J A Henry; F E May; B R Westley
Journal:  J Pathol       Date:  1991-02       Impact factor: 7.996

6.  Prediction of relapse and survival in breast cancer patients by pS2 protein status.

Authors:  J A Foekens; M C Rio; P Seguin; W L van Putten; J Fauque; M Nap; J G Klijn; P Chambon
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

7.  Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors.

Authors:  A De; D G Brown; M A Gorman; M Carr; M R Sanderson; P S Freemont
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion.

Authors:  D K Podolsky; K Lynch-Devaney; J L Stow; P Oates; B Murgue; M DeBeaumont; B E Sands; Y R Mahida
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

9.  pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

Authors:  L H Schwartz; F C Koerner; S M Edgerton; J M Sawicka; M C Rio; J P Bellocq; P Chambon; A D Thor
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

10.  pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

Authors:  J A Henry; N H Piggott; U K Mallick; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  7 in total

1.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58.

Authors:  M P Chadwick; B R Westley; F E May
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

3.  Molecular aspects of restitution: functions of trefoil peptides.

Authors:  R Poulsom; D E Begos; I M Modlin
Journal:  Yale J Biol Med       Date:  1996 Mar-Apr

Review 4.  Aspects of the biology of regeneration and repair in the human gastrointestinal tract.

Authors:  N A Wright
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

5.  Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis.

Authors:  Yueh-Mei Cheng; Meng-Ting Lu; Chuan Mei Yeh
Journal:  BMC Biotechnol       Date:  2015-05-20       Impact factor: 2.563

6.  The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the co-expression of these proteins is deregulated in gastric cancer.

Authors:  Felicity E B May; S Michael Griffin; Bruce R Westley
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

7.  The Tumor Suppressor TFF1 Occurs in Different Forms and Interacts with Multiple Partners in the Human Gastric Mucus Barrier: Indications for Diverse Protective Functions.

Authors:  Jörn Heuer; Franziska Heuer; René Stürmer; Sönke Harder; Hartmut Schlüter; Nayara Braga Emidio; Markus Muttenthaler; Dörthe Jechorek; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.